{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:08:06Z","timestamp":1788944886707,"version":"build-2803163510"},"reference-count":35,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background: Progressive supranuclear palsy (PSP) and Parkinson\u2019s disease (PD) frequently present with overlapping clinical features, creating diagnostic challenges, particularly during the early stages of disease. Structural MRI and peripheral inflammatory biomarkers may provide complementary information for differential diagnosis. Objective: To evaluate the diagnostic performance of automated pallidal volumetry and the neutrophil-to-lymphocyte ratio (NLR), individually and in combination, for distinguishing PSP from PD. Methods: This retrospective case\u2013control study included 12 patients with PSP and 12 patients with PD. Automated brain volumetry was performed using the volBrain 2.0 platform. Total pallidal volume was selected as the primary imaging biomarker based on its established involvement in PSP pathology. NLR was calculated from routine blood counts. Diagnostic performance was assessed using receiver operating characteristic (ROC) analysis. A combined MRI\u2013blood model was constructed using binary logistic regression. Results: Patients with PSP demonstrated lower normalized pallidal volumes than patients with PD. Pallidal volume showed high diagnostic performance for differentiating PSP from PD (AUC = 0.885), whereas NLR demonstrated only modest discriminatory ability (AUC = 0.715). The combined pallidal volume\u2013NLR model achieved an AUC of 0.903 compared with 0.885 for pallidal volumetry alone, but this difference was not statistically significant (DeLong p = 0.732), and sensitivity, specificity and overall accuracy remained unchanged. Conclusions: Automated pallidal volumetry provided substantially better discrimination between PSP and PD than NLR alone. Although the combined model showed a small numerical increase in AUC, this improvement was not statistically significant and did not alter sensitivity, specificity or overall accuracy. These findings do not demonstrate incremental diagnostic value of NLR beyond pallidal volumetry in this cohort. Larger prospective studies are needed to determine the clinical utility of combined MRI\u2013blood biomarker approaches in PSP.<\/jats:p>","DOI":"10.3390\/diseases14090330","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:05:43Z","timestamp":1788941143000},"page":"330","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pallidal Volumetry and Neutrophil-to-Lymphocyte Ratio in Differentiating Progressive Supranuclear Palsy from Parkinson\u2019s Disease"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8308-8121","authenticated-orcid":false,"given":"Bartosz","family":"Migda","sequence":"first","affiliation":[{"name":"Diagnostic Ultrasound Lab, Department of Pediatric Radiology, Medical University of Warsaw, 03-242 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2202-9237","authenticated-orcid":false,"given":"Micha\u0142","family":"Kuty\u0142owski","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mazovian Brodno Hospital, 03-242 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8685-475X","authenticated-orcid":false,"given":"Natalia","family":"Madetko-Alster","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Warsaw, 03-242 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"given":"Anna","family":"Migda","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Warsaw, 03-242 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"given":"Karol","family":"Kuty\u0142owski","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Warsaw, 03-242 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5371-6817","authenticated-orcid":false,"given":"Piotr","family":"Alster","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Warsaw, 03-242 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Luo, Y., Qiao, L., Li, M., Wen, X., Zhang, W., and Li, X. (2024). Global, regional, national epidemiology and trends of Parkinson\u2019s disease from 1990 to 2021: Findings from the Global Burden of Disease Study 2021. Front. Aging Neurosci., 16.","DOI":"10.3389\/fnagi.2024.1498756"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria","volume":"32","author":"Hoglinger","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41582-021-00541-5","article-title":"Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies","volume":"17","author":"Stamelou","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1007\/s00415-023-11791-2","article-title":"The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: A systematic review and meta-analysis","volume":"270","author":"Lyons","year":"2023","journal-title":"J. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1007\/s10072-021-05601-8","article-title":"\u201cParkinson\u2019s disease\u201d on the way to progressive supranuclear palsy: A review on PSP-parkinsonism","volume":"42","author":"Necpal","year":"2021","journal-title":"Neurol. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Alster, P., Madetko, N., Koziorowski, D., and Friedman, A. (2020). Progressive Supranuclear Palsy-Parkinsonism Predominant (PSP-P)-A Clinical Challenge at the Boundaries of PSP and Parkinson\u2019s Disease (PD). Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.00180"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00702-017-1717-8","article-title":"Magnetic resonance imaging for the diagnosis of Parkinson\u2019s disease","volume":"124","author":"Heim","year":"2017","journal-title":"J. Neural Transm."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Saeed, U., Lang, A.E., and Masellis, M. (2020). Neuroimaging Advances in Parkinson\u2019s Disease and Atypical Parkinsonian Syndromes. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.572976"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Alster, P., Nieciecki, M., Migda, B., Kutylowski, M., Madetko, N., Duszynska-Was, K., Charzynska, I., Koziorowski, D., Krolicki, L., and Friedman, A. (2022). The Strengths and Obstacles in the Differential Diagnosis of Progressive Supranuclear Palsy-Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA) Using Magnetic Resonance Imaging (MRI) and Perfusion Single Photon Emission Computed Tomography (SPECT). Diagnostics, 12.","DOI":"10.3390\/diagnostics12020385"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/mds.28992","article-title":"Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism from Parkinson\u2019s Disease","volume":"37","author":"Quattrone","year":"2022","journal-title":"Mov. Disord."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/WCO.0000000000001175","article-title":"Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum","volume":"36","author":"Whitwell","year":"2023","journal-title":"Curr. Opin. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.parkreldis.2018.04.005","article-title":"The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonism","volume":"54","author":"Mueller","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kim, S., Suh, C.H., Shim, W.H., and Kim, S.J. (2021). Diagnostic Performance of the Magnetic Resonance Parkinsonism Index in Differentiating Progressive Supranuclear Palsy from Parkinson\u2019s Disease: An Updated Systematic Review and Meta-Analysis. Diagnostics, 12.","DOI":"10.3390\/diagnostics12010012"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parkreldis.2018.07.016","article-title":"A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson\u2019s disease","volume":"54","author":"Quattrone","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1007\/s00415-023-11892-y","article-title":"Differentiating between common PSP phenotypes using structural MRI: A machine learning study","volume":"270","author":"Quattrone","year":"2023","journal-title":"J. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e214434","DOI":"10.1212\/WNL.0000000000214434","article-title":"Patterns of Longitudinal Regional Brain Atrophy in Patients with Different Progressive Supranuclear Palsy Clinical Variants","volume":"105","author":"Kumar","year":"2025","journal-title":"Neurology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pscychresns.2011.07.013","article-title":"Morphometric analysis of subcortical structures in progressive supranuclear palsy: In vivo evidence of neostriatal and mesencephalic atrophy","volume":"194","author":"Looi","year":"2011","journal-title":"Psychiatry Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Jasak, P., Wesolowska, A., Zoltowska, M., Alster, P., and Madetko-Alster, N. (2026). CD8+ T lymphocytes in progressive supranuclear palsy and corticobasal degeneration: Interactions with tau pathology and neuroinflammation. Park. Relat. Disord., 108917.","DOI":"10.1016\/j.parkreldis.2026.108917"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"fcaf022","DOI":"10.1093\/braincomms\/fcaf022","article-title":"Biomarkers of disease progression in progressive supranuclear palsy for use in clinical trials","volume":"7","author":"Marotta","year":"2025","journal-title":"Brain Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00702-025-02930-2","article-title":"Fluid biomarkers in atypical Parkinsonism: Current state and future perspectives","volume":"132","author":"Bougea","year":"2025","journal-title":"J. Neural Transm."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5603\/PJNNS.a2020.0097","article-title":"Neutrophil-to-lymphocyte ratio (NLR) at boundaries of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS)","volume":"55","author":"Alster","year":"2021","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s10072-019-04208-4","article-title":"The neutrophil-to-lymphocyte ratio as a marker of peripheral inflammation in progressive supranuclear palsy: A retrospective study","volume":"41","author":"Inci","year":"2020","journal-title":"Neurol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5603\/PJNNS.a2022.0014","article-title":"Platelet-to-lymphocyte ratio and neutrophil-tolymphocyte ratio may reflect differences in PD and MSA-P neuroinflammation patterns","volume":"56","author":"Madetko","year":"2022","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e16451","DOI":"10.1111\/ene.16451","article-title":"Peripheral immune profile and neutrophil-to-lymphocyte ratio in progressive supranuclear palsy: Case-control study and meta-analysis","volume":"31","author":"Zamora","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Manjon, J.V., and Coupe, P. (2016). volBrain: An Online MRI Brain Volumetry System. Front. Neuroinformatics, 10.","DOI":"10.3389\/fninf.2016.00030"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Manjon, J.V., Romero, J.E., Vivo-Hernando, R., Rubio, G., Aparici, F., de la Iglesia-Vaya, M., and Coupe, P. (2022). vol2Brain: A New Online Pipeline for Whole Brain MRI Analysis. Front. Neuroinformatics, 16.","DOI":"10.3389\/fninf.2022.862805"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Worker, A., Blain, C., Jarosz, J., Chaudhuri, K.R., Barker, G.J., Williams, S.C., Brown, R., Leigh, P.N., and Simmons, A. (2014). Cortical thickness, surface area and volume measures in Parkinson\u2019s disease, multiple system atrophy and progressive supranuclear palsy. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0114167"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/mds.29924","article-title":"Neuroinflammation Parallels 18F-PI-2620 Positron Emission Tomography Patterns in Primary 4-Repeat Tauopathies","volume":"39","author":"Malpetti","year":"2024","journal-title":"Mov. Disord."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"105480","DOI":"10.1016\/j.parkreldis.2023.105480","article-title":"Neutrophil-to-lymphocyte ratio and lymphocyte count reflect alterations in central neurodegeneration-associated proteins and clinical severity in Parkinson Disease patients","volume":"112","author":"Grillo","year":"2023","journal-title":"Park. Relat. Disord."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Li, F., Wang, Z., Deng, M., Peng, J., He, G., Tong, Y., Xu, W., Feng, T., and Song, K. (2026). Correlation of systemic immune inflammation index and systemic inflammatory response index with the severity of Parkinson\u2019s disease. Front. Neurol., 17.","DOI":"10.3389\/fneur.2026.1736318"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Li, Y.M., Xu, X.H., Ren, L.N., Xu, X.F., Dai, Y.L., Yang, R.R., and Jin, C.Q. (2024). The diagnostic value of neutrophil to lymphocyte ratio, albumin to fibrinogen ratio, and lymphocyte to monocyte ratio in Parkinson\u2019s disease: A retrospective study. Front. Neurol., 15.","DOI":"10.3389\/fneur.2024.1450221"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Yi, H., Liang, X., Xu, F., Li, T., Yang, X., Wei, M., Ou, Z., Wang, L., and Tong, Q. (2024). Association between neutrophil-to-lymphocyte ratio and motor subtypes in idiopathic Parkinson\u2019s disease: A prospective observational study. BMC Neurol., 24.","DOI":"10.1186\/s12883-024-03887-7"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Zhou, W., Zeng, T., Liu, D., Pang, R., and Gong, L. (2025). Association between inflammatory markers (SII and SIRI) and anxiety levels in Parkinson\u2019s disease. Front. Psychiatry, 16.","DOI":"10.3389\/fpsyt.2025.1635817"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1093\/brain\/awaf135","article-title":"Midbrain cytotoxic T cells as a distinct neuropathological feature of progressive supranuclear palsy","volume":"148","author":"Couto","year":"2025","journal-title":"Brain"}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/9\/330\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:32:48Z","timestamp":1788942768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/9\/330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["diseases14090330"],"URL":"https:\/\/doi.org\/10.3390\/diseases14090330","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]}}}